Single-use Device (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 01)
Risperidone Kit
Product Images NDC 70748-270
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 70748-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dose Pack Content (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 02)
Diagram illustrating the contents of a risperidone dose pack kit from Lupin Pharmaceuticals, Inc., showing labeled components: vial adapter with luer opening, spike tip, and skirt; vial containing microspheres with colored cap; prefilled syringe with plunger rod, diluent, transparent collar, and translucent gray cap; and Terumo SurGuard 3 injection needles for deltoid (1-inch) and gluteal (2-inch) use, each with transparent needle protector and needle safety device.*
Risperidone (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 03)
Chemical structure of risperidone, showing the molecular framework with rings and functional groups characteristic of the active ingredient.*
25 mg Dose Pack Carton (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 04)
Packaging label for risperiDONE for Extended-Release Injectable Suspension, 25 mg/vial. The label indicates it is a single-dose pack for deltoid or gluteal intramuscular injection only, manufactured by Lupin Pharmaceuticals, Inc. The label includes dosing instructions, a barcode, and regulatory information.*
37.5 mg Dose Pack Carton (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 05)
Packaging label for risperiDONE for Extended-Release Injectable Suspension, 37.5 mg per vial. The label shows a single-dose pack for deltoid or gluteal intramuscular injection, labeled as Rx only, manufactured by Lupin Pharmaceuticals, Inc. The layout includes dosage and usage instructions, barcode, and safety warnings on a foldable carton template.*
50 mg Dose Pack Carton (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 06)
Packaging label for risperidone extended-release injectable suspension, 50 mg per vial, presented as a single-dose pack. The label directs use for deltoid or gluteal intramuscular injection, provides instructions to read complete use information prior to use, and notes the product is Rx only. The labeler is Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 10)
An instructional illustration showing a hand holding a capped test tube or vial with the label "Incorrect" indicated at the top, suggesting the depicted handling is not the proper method.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 11)
An instructional illustration showing a syringe with the cap removed. Text below states, "When the cap is removed, the syringe will look like this." This image is part of a risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 12)
An instructional illustration showing a hand holding a small vial or container while the other hand is unscrewing or removing a cap or stopper. An arrow indicates the direction of removal. This diagram likely demonstrates how to open or prepare a component of the risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 13)
An instructional illustration showing a hand holding a vial while another hand inserts a syringe needle into the vial's stopper. An arrow indicates downward pressure on the syringe plunger, and a curved arrow suggests twisting motion on the vial stopper. This diagram is likely part of a kit for risperidone, demonstrating how to withdraw medication from the vial.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 2)
An illustration showing a rectangular box and a clock icon indicating a 30-minute time interval, suggesting a waiting or delay period relevant to a risperidone kit usage step.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 3)
An instructional illustration showing a hand removing a flip cap from a small vial or bottle. The vial appears to be part of a medication kit, likely for risperidone, with a focus on how to open the container properly.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 4)
An instructional illustration showing hands preparing a nasal spray device, with fingers holding and removing a protective cover from the nasal applicator tip.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 5)
An instructional illustration showing a hand holding a vial and another hand pressing down on a blister pack with an arrow indicating a downward motion, likely demonstrating how to access medication from the packaging.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 6)
An instructional illustration showing how to open or assemble a component of the risperidone kit by twisting or lifting a cap or lid. The image depicts hands manipulating the kit parts, likely demonstrating preparation steps for administration or use.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 7)
Text instructions advising to remove the vial adapter from the sterile blister only when ready to remove the translucent gray cap from the prefilled syringe. The instructions are presented in a boxed warning style with a caution symbol.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 8)
An instructional illustration showing a person removing the cap from a small vial using their thumb and forefinger, with an upward arrow indicating the direction to lift the cap. This image is part of a risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 37 9)
An illustration showing a hand grasping and pulling a tab or strip, likely demonstrating how to open or use a component of the risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 38 2)
Instructional text describing handling of a vial: "Vial contents will now be under pressure. Keep holding the plunger rod down with thumb." This instruction appears in a rectangular box with a warning icon on the top left.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 38 3)
An instructional illustration showing hands holding a vial and a syringe. The syringe is being inserted into the vial, with an arrow indicating downward movement to draw medication from the vial.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 38 4)
An instructional diagram showing hands holding a risperidone kit component with an arrow indicating a twisting motion and a timer icon displaying 10 seconds. The illustration likely demonstrates part of the preparation or activation process for the risperidone kit dosage form by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 38 5)
An instructional illustration showing a vial held upside down with a hand attaching or withdrawing liquid into a syringe. A large downward arrow indicates the direction of movement, demonstrating the process of drawing medication from the vial into the syringe.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 38 6)
An instructional illustration depicting the preparation of a syringe. The image shows a hand holding a syringe and another hand holding a vial, with arrows indicating the removal of a cap or seal from the vial before attaching it to the syringe. This likely relates to the use or administration of risperidone in a kit form by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 39 2)
An instructional diagram showing recommended injection sites and needle insertion depths for risperidone KIT. It illustrates the deltoid muscle site with a 1-inch needle and the gluteal muscle site with a 2-inch needle, each accompanied by a syringe graphic indicating needle length.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 39 3)
An instructional illustration showing hands opening a blister pack by peeling back the foil. The focus is on how to access the medication within the pack, demonstrating a step in the administration or preparation process for the risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 39 4)
An instructional illustration showing a hand gripping a twisted object, with arrows indicating a twisting or pulling motion along the object's length, suggesting a technique for opening or manipulating a component, possibly related to the risperidone kit packaging or administration.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 40 2)
An instructional diagram illustrating the use of a dosing device or applicator. It shows a hand manipulating the device by pulling a lever or cap, with arrows indicating the direction of movement to prepare or activate the product for use.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 40 3)
An instructional illustration showing a hand holding a syringe with the cap being removed by another hand pulling upwards. This depicts the initial step in preparing the risperidone kit for use.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 40 4)
An anatomical line drawing of the human back with two arrows pointing to areas on the upper back and lower back above the waist, indicating locations for possible application or focus related to the risperidone kit.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 40 5)
An instructional illustration showing how to open or prepare a component from a kit. It depicts a hand twisting or breaking a segment of a container or vial, with a close-up circle emphasizing the 'AFTER' state of the opened or separated part, likely part of the risperidone kit by Lupin Pharmaceuticals, Inc.*
Image (E3ee0cf1 Acf1 4641 A64b 56d5e73f2aac 40 6)
An instructional illustration showing a human hand holding a small object with tweezers above a biohazard waste container with an open lid. The container is marked with a biohazard symbol, indicating proper disposal of the object, likely related to the use or disposal of a medical or pharmaceutical kit component.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
